Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
The First-Ever Personalized Cancer Vaccine to Pass a Phase 3 Trial Just Beat Keytruda Alone
2
Cat-Camel Exercise: A Gentle Way to Improve Spine Mobility During Cancer Recovery
3
Why Gene Silencing Could Change Polycythemia Vera Treatment
4
She Was the One Everyone Counted On: When a Mother and Wife Gets Cancer
5